Lineage Cell Therapeutics, Inc.LCTXNYSE
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average, slight contraction.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-23.66M
↑ 18% above average
Average (9y)
$-28.91M
Historical baseline
Range
High:$646000.00
Low:$-49.88M
CAGR
-8.0%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $-23.66M | +19.1% |
| 2023 | $-29.24M | -4626.3% |
| 2022 | $646000.00 | +102.7% |
| 2021 | $-23.91M | -20.7% |
| 2020 | $-19.82M | +38.8% |
| 2019 | $-32.39M | +5.2% |
| 2018 | $-34.17M | -7.3% |
| 2017 | $-31.84M | +29.0% |
| 2016 | $-44.85M | +10.1% |
| 2015 | $-49.88M | - |